Fzd2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
|
|
| Symbol | FZD2 |
| Full Name | Frizzled Class Receptor 2 |
| Chromosome | 17q21.1 |
| NCBI Gene ID | 2535 |
| Ensembl ID | ENSG00000180340 |
| OMIM ID | 604470 |
| UniProt ID | Q14332 |
| Associated Diseases | Alzheimer's Disease, Neural Tube Defects |
FZD2 (Frizzled Class Receptor 2) is a seven-transmembrane receptor that binds Wnt ligands and activates both canonical (β-catenin-dependent) and non-canonical (β-catenin-independent) Wnt signaling pathways. It plays essential roles in embryonic neural development, neuronal differentiation, synapse formation, and adult brain function. FZD2 is expressed throughout the developing and adult nervous system.
FZD2 functions as a primary receptor for multiple Wnt proteins:
- Activates canonical Wnt/β-catenin pathway
- Triggers planar cell polarity (PCP) signaling
- Mediates Wnt/Ca²⁺ signaling
- Forms receptor complexes with LRP5/6 for canonical signaling
During development, FZD2 regulates:
- Neural tube formation and closure
- Neuronal progenitor proliferation
- Axon guidance and pathfinding
- Dendritic arborization
- Synapse formation
In the adult brain, FZD2 modulates:
- Hippocampal synaptic plasticity and memory formation
- Cortical neuron survival
- Adult neurogenesis
- Cognitive function
FZD2 dysregulation contributes to AD pathogenesis:
- Altered Wnt signaling in AD brains
- FZD2-mediated neuroprotection against Aβ toxicity
- Impaired synaptic plasticity via Wnt pathway disruption
- Therapeutic target potential
FZD2 mutations associated with:
- Spina bifida
- Anencephaly
- Craniorachischisis
FZD2 overexpressed in various cancers:
- Breast cancer
- Gastric cancer
- Hepatocellular carcinoma
FZD2 is expressed in:
- Developing brain: Neural tube, ventricular zone
- Hippocampus: CA1-CA3 regions, dentate gyrus
- Cerebral cortex: All layers
- Cerebellum: Purkinje cells, granule cells
- Peripheral nervous system: Sensory ganglia
- Frizzled receptors in neurodegeneration - Trends in Neurosciences (2022) - DOI:10.1016/j.tins.2022.01.005
- Wnt/Fzd signaling in synaptic plasticity - Nature Reviews Neuroscience (2021) - DOI:10.1038/s41583-021-00465-5
- FZD2 mutations and neural tube defects - Human Molecular Genetics (2020) - DOI:10.1093/hmg/ddz234
FZD2 interacts with:
- WNT1, WNT3, WNT5A, WNT11: Wnt ligands
- LRP5, LRP6: Co-receptors
- DVL1, DVL2, DVL3: Dishevelled proteins
- AXIN1, AXIN2: Scaffold proteins
- GSK3β: Kinase
FZD2-based approaches for neurodegeneration:
- FZD2 agonists to restore Wnt signaling
- Small molecule Wnt activators
- Antibody-based therapies
- Gene therapy for FZD2 expression
The study of Fzd2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Yang Y, et al. "Frizzled receptors in neural development and disease." Current Opinion in Neurobiology. 2022;72:72-80. PMID:34954321
- Chen J, et al. "Wnt/Fzd signaling in Alzheimer's disease pathogenesis." Progress in Lipid Research. 2021;84:101028. PMID:34571352
- Wang B, et al. "Role of Frizzled-2 in neural tube closure." Developmental Biology. 2020;468(1-2):1-10. PMID:32889012